Literature DB >> 32680954

SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.

Daniel M Altmann1, Rosemary J Boyton2,3.   

Abstract

In efforts to synthesize a clear understanding of SARS-CoV-2 protective immunity, antibody analysis has been paralleled by T cell studies across asymptomatic, mild and severe COVID-19. Defining CD4 and CD8 effector functions in protection is important considering that antibody responses appear short-lived and T cell memory is potentially more durable. To fully understand population level immunity, screening for both antibody and T cell immunity using standardized testing methods would be beneficial.
Copyright © 2020, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32680954     DOI: 10.1126/sciimmunol.abd6160

Source DB:  PubMed          Journal:  Sci Immunol        ISSN: 2470-9468


  90 in total

Review 1.  Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection.

Authors:  Seyed Hamid Safiabadi Tali; Jason J LeBlanc; Zubi Sadiq; Oyejide Damilola Oyewunmi; Carolina Camargo; Bahareh Nikpour; Narges Armanfard; Selena M Sagan; Sana Jahanshahi-Anbuhi
Journal:  Clin Microbiol Rev       Date:  2021-05-12       Impact factor: 26.132

2.  SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition.

Authors:  Daniel M Altmann; Catherine J Reynolds; Rosemary J Boyton
Journal:  Cell Rep Med       Date:  2021-05-18

3.  Dynamics of anti-SARS-CoV-2 IgG antibodies post-COVID-19 in a Brazilian Amazon population.

Authors:  Carlos David Araújo Bichara; Ednelza da Silva Graça Amoras; Gergiane Lopes Vaz; Maria Karoliny da Silva Torres; Maria Alice Freitas Queiroz; Isabella Pinheiro Costa do Amaral; Izaura Maria Vieira Cayres Vallinoto; Cléa Nazaré Carneiro Bichara; Antonio Carlos Rosário Vallinoto
Journal:  BMC Infect Dis       Date:  2021-05-15       Impact factor: 3.090

4.  SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses.

Authors:  Benedikt Agerer; Maximilian Koblischke; Venugopal Gudipati; Luis Fernando Montaño-Gutierrez; Mark Smyth; Alexandra Popa; Jakob-Wendelin Genger; Lukas Endler; David M Florian; Vanessa Mühlgrabner; Marianne Graninger; Stephan W Aberle; Anna-Maria Husa; Lisa Ellen Shaw; Alexander Lercher; Pia Gattinger; Ricard Torralba-Gombau; Doris Trapin; Thomas Penz; Daniele Barreca; Ingrid Fae; Sabine Wenda; Marianna Traugott; Gernot Walder; Winfried F Pickl; Volker Thiel; Franz Allerberger; Hannes Stockinger; Elisabeth Puchhammer-Stöckl; Wolfgang Weninger; Gottfried Fischer; Wolfgang Hoepler; Erich Pawelka; Alexander Zoufaly; Rudolf Valenta; Christoph Bock; Wolfgang Paster; René Geyeregger; Matthias Farlik; Florian Halbritter; Johannes B Huppa; Judith H Aberle; Andreas Bergthaler
Journal:  Sci Immunol       Date:  2021-03-04

Review 5.  Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages.

Authors:  Pureum Lee; Chang-Ung Kim; Sang Hawn Seo; Doo-Jin Kim
Journal:  Immune Netw       Date:  2021-02-26       Impact factor: 6.303

6.  Systematic Examination of Antigen-Specific Recall T Cell Responses to SARS-CoV-2 versus Influenza Virus Reveals a Distinct Inflammatory Profile.

Authors:  Jaclyn C Law; Wan Hon Koh; Patrick Budylowski; Jonah Lin; FengYun Yue; Kento T Abe; Bhavisha Rathod; Melanie Girard; Zhijie Li; James M Rini; Samira Mubareka; Allison McGeer; Adrienne K Chan; Anne-Claude Gingras; Tania H Watts; Mario A Ostrowski
Journal:  J Immunol       Date:  2020-11-18       Impact factor: 5.422

Review 7.  Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2.

Authors:  Pankaj Ahluwalia; Kumar Vaibhav; Meenakshi Ahluwalia; Ashis K Mondal; Nikhil Sahajpal; Amyn M Rojiani; Ravindra Kolhe
Journal:  Front Immunol       Date:  2021-05-11       Impact factor: 7.561

8.  Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs.

Authors:  Shira Weingarten-Gabbay; Susan Klaeger; Siranush Sarkizova; Leah R Pearlman; Da-Yuan Chen; Kathleen M E Gallagher; Matthew R Bauer; Hannah B Taylor; W Augustine Dunn; Christina Tarr; John Sidney; Suzanna Rachimi; Hasahn L Conway; Katelin Katsis; Yuntong Wang; Del Leistritz-Edwards; Melissa R Durkin; Christopher H Tomkins-Tinch; Yaara Finkel; Aharon Nachshon; Matteo Gentili; Keith D Rivera; Isabel P Carulli; Vipheaviny A Chea; Abishek Chandrashekar; Cansu Cimen Bozkus; Mary Carrington; Nina Bhardwaj; Dan H Barouch; Alessandro Sette; Marcela V Maus; Charles M Rice; Karl R Clauser; Derin B Keskin; Daniel C Pregibon; Nir Hacohen; Steven A Carr; Jennifer G Abelin; Mohsan Saeed; Pardis C Sabeti
Journal:  Cell       Date:  2021-06-03       Impact factor: 66.850

9.  Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice.

Authors:  Adrian Rice; Mohit Verma; Annie Shin; Lise Zakin; Peter Sieling; Shiho Tanaka; Joseph Balint; Kyle Dinkins; Helty Adisetiyo; Brett Morimoto; Wendy Higashide; C Anders Olson; Shivani Mody; Patricia Spilman; Elizabeth Gabitzsch; Jeffrey T Safrit; Shahrooz Rabizadeh; Kayvan Niazi; Patrick Soon-Shiong
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

10.  Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells.

Authors:  Catherine Riou; Georgia Schäfer; Elsa du Bruyn; Rene T Goliath; Cari Stek; Huihui Mou; Deli Hung; Katalin A Wilkinson; Robert J Wilkinson
Journal:  Eur Respir J       Date:  2022-01-13       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.